| Secondary |
| Hypertension |
34.2% |
| Drug Use For Unknown Indication |
23.1% |
| Product Used For Unknown Indication |
16.4% |
| Pain |
3.6% |
| Anxiety |
2.5% |
| Hepatitis B |
2.5% |
| Thrombocytopenic Purpura |
2.1% |
| Hypercholesterolaemia |
1.9% |
| Essential Hypertension |
1.7% |
| Back Pain |
1.3% |
| Constipation |
1.3% |
| Haemolytic Uraemic Syndrome |
1.3% |
| Osteoarthritis |
1.3% |
| Prophylaxis |
1.3% |
| Psoriasis |
1.3% |
| Abnormal Behaviour |
1.0% |
| Depression |
1.0% |
| Atrial Fibrillation |
0.8% |
| Bronchial Carcinoma |
0.8% |
| Chronic Obstructive Pulmonary Disease |
0.8% |
|
| Renal Failure Acute |
13.8% |
| Aortic Dissection |
8.8% |
| Orthostatic Hypotension |
8.8% |
| Weight Decreased |
7.5% |
| Agranulocytosis |
6.3% |
| Vomiting |
6.3% |
| Fall |
5.0% |
| Renal Failure |
5.0% |
| Toxic Skin Eruption |
5.0% |
| Guillain-barre Syndrome |
3.8% |
| Parkinsonism |
3.8% |
| Photophobia |
3.8% |
| Pruritus |
3.8% |
| Rash |
3.8% |
| Angioedema |
2.5% |
| Confusional State |
2.5% |
| Disturbance In Attention |
2.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.5% |
| Haematemesis |
2.5% |
| Hepatic Enzyme Abnormal |
2.5% |
|
| Concomitant |
| Hypertension |
29.5% |
| Product Used For Unknown Indication |
19.1% |
| Drug Use For Unknown Indication |
17.7% |
| Ischaemic Cardiomyopathy |
3.5% |
| Hiv Infection |
3.3% |
| Myocardial Ischaemia |
3.3% |
| Unevaluable Event |
2.7% |
| Diabetes Mellitus |
2.4% |
| Hypercholesterolaemia |
2.1% |
| Neuralgia |
2.0% |
| Type 2 Diabetes Mellitus |
1.9% |
| Prophylaxis |
1.8% |
| Renal Transplant |
1.8% |
| Peritoneal Dialysis |
1.5% |
| Hypothyroidism |
1.4% |
| Osteoporosis |
1.4% |
| Atrial Fibrillation |
1.3% |
| Depression |
1.2% |
| Pain |
1.1% |
| Anxiety |
1.0% |
|
| Renal Failure Acute |
11.1% |
| Renal Failure |
10.3% |
| Thrombocytopenia |
7.0% |
| Peritoneal Haemorrhage |
6.6% |
| Weight Increased |
6.6% |
| Hyperkalaemia |
6.2% |
| Urticaria |
5.8% |
| Pyrexia |
4.9% |
| Vomiting |
4.9% |
| Weight Decreased |
4.9% |
| Toxic Skin Eruption |
4.1% |
| Malaise |
3.7% |
| Death |
3.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.3% |
| Eosinophilia |
3.3% |
| Urinary Tract Infection |
3.3% |
| Purpura |
2.9% |
| Renal Impairment |
2.9% |
| Pancytopenia |
2.5% |
| Rhabdomyolysis |
2.5% |
|
| Interacting |
| Hypertensive Heart Disease |
30.0% |
| Hypertension |
15.0% |
| Depression |
7.5% |
| Hyperuricaemia |
7.5% |
| Hypokalaemia |
7.5% |
| Prophylaxis |
7.5% |
| Prostate Cancer |
7.5% |
| Transient Ischaemic Attack |
7.5% |
| Drug Use For Unknown Indication |
5.0% |
| Essential Hypertension |
5.0% |
|
| Renal Failure Acute |
33.3% |
| Orthostatic Hypotension |
22.2% |
| Drug Interaction |
11.1% |
| Rhabdomyolysis |
11.1% |
| Tachyarrhythmia |
11.1% |
| Tachycardia |
11.1% |
|
